MicroPort® NeuroTech（Shanghai）Co., Ltd.

News

声明：本版块内容仅做新闻和科普用途，不应被视为对所涉医疗产品的推荐或功效证明。涉及疾病诊断、治疗、康复相关的，请务必前往专业医疗机构就诊。如任何个人或其他媒体、网站欲转载，请与本网站联系授权，并注明转载来源。

2023-05-19

MicroPort NeuroTech™ has completed the first clinical implantation of NUMEN™Detachable Embolization Coil in Ireland

Dublin, Ireland - Recently, MicroPort NeuroTech™ (Shanghai) Co., Ltd., (hereinafter referred to as "MicroPort NeuroTech™"), completed the first clinical implantation of NUMEN™ Detachable Embolization Coil (hereinafter referred to as "NUMEN™ coil")at Beaumont Hospital in Ireland
2023-03-28

MicroPort Neurotech™ Receives MDSAP Certificate

Shanghai, China, 28 March 2023 - MicroPort NeuroTech Limited (MicroPort NeuroTech™) recently announced that it has received a Medical Device Single Audit Program (MDSAP) certificate from the Technischer Überwachungs-Verein (TÜV SÜD), an international notified body, certifying MicroPort
2022-08-27

MicroPort NeuroTech™ Announces 2022 Interim Results

Shanghai, China, 27 August 2022 – MicroPort NeuroTech Limited (“MicroPort NeuroTech™” or the “Company”) today announced the interim results of the Company and its subsidiaries for the six months ended 30 June 2022 (the “Reporting Period”).
2022-08-27

MicroPort NeuroTech™ NUMEN Coil Embolization System Receives Marketing Approval in Japan

Tokyo, Japan, 22 August 2022 – MicroPort Neurotech Limited (“MicroPort NeuroTech™”), a pioneering Chinese company in the field of neurovascular interventional treatment, today announced that it has received marketing approval issued by Ministry of Health, Labour and Welfare Japan for its independently-developed Numen™ Coil Embolization System (“Numen™”), marking the first approved product in Japan for MicroPort NeuroTech™.
2022-08-25

MicroPort NeuroTech™ Completes First Implantations of NUMEN™ Coil Embolization System in Poland

Krakow/Kielce, Poland, 10 August 2022 — MicroPort Neurotech Limited (“MicroPort NeuroTech™”) recently announced that its independently developed Numen™ Coil Embolization System (“Numen™”) has been successfully used in the first two implantations in Poland. Numen™’s deliverability and detac
2022-07-15

MicroPort NeuroTech™ Debuts on Main Board of HKEX

As the Pioneer & Largest Chinese Player in the Neuro-interventional Medical Device Industry.
2022-06-28

MicroPort NeuroTech™ Completes First Implantation of Numen™ Coil Embolization System in the U.S.

Boston, United States/Shanghai, China, 28 June 2022 - MicroPort Neurotech Limted (hereafter referred to as “MicroPort NeuroTech™” of the “Company”), a pioneering Chinese company in the field of neurovascular interventional treatment, today announced it has successfully completed the first comm.
2022-04-22

MicroPort NeuroTech™ Receives NMPA Marketing Approval for the X-track™ Intracranial Distal Access Catheter

The approved X-track™ is made of special polymer materials and a braided structure with two filaments that can reach the lesion site repeatedly during the procedure.
2022-03-11

MicroPort NeuroTech™ Receives NMPA Marketing Approval for its NUMEN Silk^® 3-D Coil Embolization System

MicroPort NeuroTech™ Receives NMPA Marketing Approval for its NUMEN Silk^® 3-D Coil Embolization System.
2022-03-04

MicroPort NeuroTech™ NUMEN^® Coil Embolization System Listed for Reimbursement under Korea’s National Health Insurance System

MicroPort NeuroTech™ NUMEN® has been approved for entry into the Korean health insurance scheme and for inclusion into the reimbursement list. This means that NUMEN^® is not only approved for use in Korean hospitals, but also reimbursable under the national health insurance program.

1 2 3 4 5

手机：

(86)19542912295

电话：

(86) (21)38954600-55200

地址：

1661 Zhangdong Road, Zhangjiang High-tech Park, Pudong New District, Shanghai, PRC

传真：

(21) 50801305

关于我们

患者关怀

投资者关系

人才中心

新闻资讯

友情链接

微创®医疗

沪ICP备19033024号-3 微信图片_20200506140817.png 沪公网安备 31011502401776号

网站仅供医疗专业人士参考

News

MicroPort NeuroTech™ has completed the first clinical implantation of NUMEN™Detachable Embolization Coil in Ireland

MicroPort Neurotech™ Receives MDSAP Certificate

MicroPort NeuroTech™ Announces 2022 Interim Results

MicroPort NeuroTech™ NUMEN Coil Embolization System Receives Marketing Approval in Japan

MicroPort NeuroTech™ Completes First Implantations of NUMEN™ Coil Embolization System in Poland

MicroPort NeuroTech™ Debuts on Main Board of HKEX

MicroPort NeuroTech™ Completes First Implantation of Numen™ Coil Embolization System in the U.S.

MicroPort NeuroTech™ Receives NMPA Marketing Approval for the X-track™ Intracranial Distal Access Catheter

MicroPort NeuroTech™ Receives NMPA Marketing Approval for its NUMEN Silk® 3-D Coil Embolization System

MicroPort NeuroTech™ NUMEN® Coil Embolization System Listed for Reimbursement under Korea’s National Health Insurance System

MicroPort NeuroTech™ Receives NMPA Marketing Approval for its NUMEN Silk^® 3-D Coil Embolization System

MicroPort NeuroTech™ NUMEN^® Coil Embolization System Listed for Reimbursement under Korea’s National Health Insurance System